Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TLX.AX | ||||
| Company | Telix Pharmaceuticals Ltd | ||||
| Price Information | |||||
| Exchange | ASX | ||||
| Open | 11.140 | ||||
| High | 11.515 | ||||
| Low | 11.040 | ||||
| Latest | 11.480 | ||||
| Change | +0.330 | ||||
| % Change | +2.96% | ||||
| Volume | 3,582,456 | ||||
| 20-Day Average Volume | 2,260,437 | ||||
| Previous Close | 11.150 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 11.440 | ||||
| 20-Day Raw Stochastic | 32.25% | ||||
| 20-Day Relative Strength | 37.15 | ||||
| Weighted Alpha | -60.50 | ||||
| Today's Opinion | 88% Sell | ||||
| Previous Opinion | 100% Sell | ||||
| Last Month's Opinion | 100% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 01/09/26 | ||||
| Low | 10.930 on 01/13/26 | ||||
| High | 11.515 on 01/16/26 | ||||
| 1-Month | |||||
| %Chg | -8.60% since 12/16/25 | ||||
| Low | 10.885 on 01/06/26 | ||||
| High | 12.730 on 12/17/25 | ||||
| 3-Month | |||||
| %Chg | -32.23% since 10/16/25 | ||||
| Low | 10.885 on 01/06/26 | ||||
| High | 17.250 on 10/21/25 | ||||
| 6-Month | |||||
| %Chg | -52.23% since 07/16/25 | ||||
| Low | 10.885 on 01/06/26 | ||||
| High | 25.410 on 07/21/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 3,732,178 | ||||
| Shares Outstanding, K | 334,724 | ||||
| Annual Sales | 487,020,570 | ||||
| Annual Net Income | 31,041,066 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | 319.58 | ||||